Privium Fund Management’s BriaCell Therapeutics Corp. Warrant BCTXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-64,907
| Closed | -$159K | – | 116 |
|
|
2023
Q2 | $159K | Sell |
64,907
-57,177
| -47% | -$140K | 0.05% | 76 |
|
|
2023
Q1 | $361K | Sell |
122,084
-196,876
| -62% | -$583K | 0.12% | 53 |
|
|
2022
Q4 | $622K | Buy |
318,960
+45,306
| +17% | +$88.3K | 0.24% | 43 |
|
|
2022
Q3 | $710K | Buy |
273,654
+78,837
| +40% | +$205K | 0.26% | 49 |
|
|
2022
Q2 | $507K | Buy |
+194,817
| New | +$507K | 0.17% | 65 |
|